4//SEC Filing
LAWRENCE DAVID 4
Accession 0001209191-19-012973
CIK 0001008848other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 4:17 PM ET
Size
5.2 KB
Accession
0001209191-19-012973
Insider Transaction Report
Form 4
LAWRENCE DAVID
Chief Financial Officer
Transactions
- Sale
Common Stock
2019-02-22$13.18/sh−761$10,028→ 5,092 total
Footnotes (2)
- [F1]Reflects the number of shares of the issuer's Common Stock that were sold to cover tax liability in connection with settlement of restricted stock units that vested as reported on a prior Form 4.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $12.9666 to $13.18000 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
ACORDA THERAPEUTICS INC
CIK 0001008848
Entity typeother
Related Parties
1- filerCIK 0001272353
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 4:17 PM ET
- Size
- 5.2 KB